Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
4.900
-0.050 (-1.01%)
May 13, 2025, 4:00 PM - Market closed

Xeris Biopharma Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Cash & Equivalents
58.4471.6267.45121.9767.2737.6
Upgrade
Short-Term Investments
--5-35.1696.19
Upgrade
Cash & Short-Term Investments
58.4471.6272.45121.97102.43133.79
Upgrade
Cash Growth
-33.10%-1.15%-40.60%19.07%-23.44%77.09%
Upgrade
Accounts Receivable
46.3340.4239.230.8317.466.88
Upgrade
Receivables
46.3340.4239.230.8317.466.88
Upgrade
Inventory
52.6948.1838.8424.7418.128.35
Upgrade
Prepaid Expenses
6.037.455.789.294.593.2
Upgrade
Total Current Assets
163.49167.66156.26186.82142.6152.21
Upgrade
Property, Plant & Equipment
27.7928.2129.189.516.636.71
Upgrade
Goodwill
22.8622.8622.8622.8622.86-
Upgrade
Other Intangible Assets
96.2198.92109.76120.61131.45-
Upgrade
Other Long-Term Assets
5.15.414.544.730.830.23
Upgrade
Total Assets
315.45323.06322.6344.52304.36159.15
Upgrade
Accounts Payable
6.352.2911.574.618.923.12
Upgrade
Accrued Expenses
50.7856.845.6644.0951.1721.07
Upgrade
Current Portion of Long-Term Debt
11.9615.1----
Upgrade
Current Portion of Leases
6.126.083.51.58--
Upgrade
Other Current Liabilities
19.8620.1734.4723.3518.954.02
Upgrade
Total Current Liabilities
95.07100.4495.1973.6279.0428.21
Upgrade
Long-Term Debt
217.81217.01190.93187.0888.0787.02
Upgrade
Long-Term Leases
32.8733.2634.769.4--
Upgrade
Long-Term Deferred Tax Liabilities
--2.273.524.94-
Upgrade
Other Long-Term Liabilities
4.831.976.2325.7237.0810.16
Upgrade
Total Liabilities
350.58352.68329.38299.34209.13125.39
Upgrade
Common Stock
0.020.020.010.010.010.01
Upgrade
Additional Paid-In Capital
645.96642.26610.25599.97555.36371.13
Upgrade
Retained Earnings
-681.08-671.86-617.03-554.77-460.11-337.39
Upgrade
Comprehensive Income & Other
-0.03-0.03-0.03-0.02-0.030.01
Upgrade
Total Common Equity
-35.13-29.62-6.7845.1995.2333.76
Upgrade
Shareholders' Equity
-35.13-29.62-6.7845.1995.2333.76
Upgrade
Total Liabilities & Equity
315.45323.06322.6344.52304.36159.15
Upgrade
Total Debt
268.75271.45229.19198.0688.0787.02
Upgrade
Net Cash (Debt)
-210.31-199.83-156.74-76.0914.3746.77
Upgrade
Net Cash Growth
-----69.28%171.21%
Upgrade
Net Cash Per Share
-1.40-1.36-1.14-0.560.181.10
Upgrade
Filing Date Shares Outstanding
160.16153.94140.45137.29135.5259.76
Upgrade
Total Common Shares Outstanding
156.01149.43138.13136.27124.8759.61
Upgrade
Working Capital
68.4267.2261.07113.263.56124.01
Upgrade
Book Value Per Share
-0.23-0.20-0.050.330.760.57
Upgrade
Tangible Book Value
-154.2-151.4-139.41-98.28-59.0833.76
Upgrade
Tangible Book Value Per Share
-0.99-1.01-1.01-0.72-0.470.57
Upgrade
Machinery
6.276.265.655.685.434.32
Upgrade
Leasehold Improvements
6.066.065.985.075.034.63
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q